Otsuka Holdings Co., Ltd. engages in the management of its group companies which are in the pharmaceuticals business. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 35,338 full-time employees. The company went IPO on 2010-12-15. The firm operates in four business segments. The Medical Business segment produces and sells therapeutic drugs and infusions. The Nutraceutical segment produces and sells functional beverages, quasi-drugs and nutritional supplements. The Consumer Products segment produces and sells mineral water, beverages and food products. The Others segment manufactures paper containers, manufactures synthetic resin molded products, stores products, provides storage space, and produces and sells chemicals and liquid crystal evaluation equipment, spectroscopic analysis equipment, and other products.
How did OTSKY's recent EPS compare to expectations?
The most recent EPS for Otsuka Holdings Co., Ltd. is $186.31, beating expectations of $137.63.
How did Otsuka Holdings Co., Ltd. OTSKY's revenue perform in the last quarter?
Otsuka Holdings Co., Ltd. revenue for the last quarter is $186.31
What is the revenue estimate for Otsuka Holdings Co., Ltd.?
According to 6 of Wall street analyst, the revenue estimate of Otsuka Holdings Co., Ltd. range from $688.56B to $607.01B
What's the earning quality score for Otsuka Holdings Co., Ltd.?
Otsuka Holdings Co., Ltd. has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Otsuka Holdings Co., Ltd. report earnings?
Otsuka Holdings Co., Ltd. next earnings report is expected in 2026-07-27
What are Otsuka Holdings Co., Ltd.'s expected earnings?
Otsuka Holdings Co., Ltd. expected earnings is $598.59B, according to wall-street analysts.
Did Otsuka Holdings Co., Ltd. beat earnings expectations?
Otsuka Holdings Co., Ltd. recent earnings of $630.34B beat expectations.